Oxygen-guided therapy for optimal rehabilitation for peripheral artery disease

Ended Project Grant Awarded Last action

Award ID
R41AG074788
Recipient
Awarding agency
Obligated
$755,783

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Funding
  • $508,480.00 Federal
  • $247,303.00 Non-federal
Place of performance
Athens, GA 30602, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
This workforce diversity supplement proposal seeks to create an opportunity to enhance the resources, environment, and culture of infrared RX in our organization's efforts to advance technology to serve patients suffering from disabling peripheral artery disease. At the same time, IT reflects our commitment to promoting a diverse workforce and to further career development for underrepresented groups in science and business. In this proposal, we have created a role within the organization for the candidate to expand knowledge, acquire skills, and shape attitudes in science, medicine, and entrepreneurship. Meanwhile, this role will add value to our company, the technology we develop, and the patients we seek to serve.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $6,937 $0
Amendment $6,937 $0
Amendment $247,303 $0
Original award $247,303 $247,303

Quick answers

Who received award R41AG074788?

R41AG074788 was awarded to Infrared RX, Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2021.

How much is award R41AG074788 worth?

$755,783 has been obligated on R41AG074788: $508,480 in federal funding and $247,303 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login